Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bristol-Myers Squibb
Filamon LTD
PMV Pharmaceuticals, Inc
Mayo Clinic
Tomsk National Research Medical Center of the Russian Academy of Sciences
Thomas Jefferson University
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
ViroMissile, Inc.
University of California, Davis
Replimune Inc.
Carevive Systems, Inc.
University of Pennsylvania
University of Florida
Tizona Therapeutics, Inc
Essen Biotech
Clasp Therapeutics, Inc.
Ulsan University Hospital
Baylor College of Medicine
University of Colorado, Denver
Poitiers University Hospital
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Centre Paul Strauss
Case Comprehensive Cancer Center
SystImmune Inc.
Daiichi Sankyo
University of Michigan Rogel Cancer Center
Kidney Cancer Research Bureau
HealthPartners Institute
M.D. Anderson Cancer Center
Second Life Therapeutics
University of Kansas Medical Center
Eli Lilly and Company
NRG Oncology
NRG Oncology
Medical College of Wisconsin
Fred Hutchinson Cancer Center
Eli Lilly and Company
Varian, a Siemens Healthineers Company
Novartis
Sichuan Baili Pharmaceutical Co., Ltd.
Var2 Pharmaceuticals
Ohio State University Comprehensive Cancer Center